Regulatory mechanisms for senescence marker protein 30 expression
Regulatory mechanisms for senescence marker protein 30 expression
批准号:
23500838
负责人:
ARAI Hideaki
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2013
中文摘要
衰老标志蛋白30(SMP30)是一种在衰老大鼠肝脏中显著减少的标志蛋白。调控SMP30表达的分子机制尚不清楚。阐明这种调节机制对于制定防治与年龄相关的体能下降和与年龄相关的疾病的对策至关重要。衰老是一个高度调控的过程,具有进化保守的信号转导机制,其中胰岛素样生长因子信号转导(IIS)起着重要作用。在这项研究中,我发现SMP30在人HepG2细胞中的表达受到IIS的调控。对人类SMP30基因的详细分析表明,SMP30受蠕虫长寿基因daf-16同源的Forkhead box转录因子O类(FoxO)调控。然而,直接证明FoxO参与是不可行的,因为SMP30在HepG2中的表达水平极低,这可能反映了缺乏调节FoxO的辅因子(S)。
英文摘要
Senescence marker protein 30 (SMP30) was identified as a marker protein which shows substantial decrease in ageing rat liver. The molecular mechanisms regulating SMP30 expression is unclear. Elucidation of this regulatory mechanisms is crucial for development of countermeasures against age-related decline of physical fitness and age-associated diseases. Ageing is a highly regulated process with evolutionally conserved signal transduction mechanisms, among which insulin-insulin like growth factor signaling (IIS) is predominantly important. In this study, I found that SMP30 expression in human HepG2 cells was regulated by IIS. Detailed analysis of human SMP30 gene indicated that SMP30 is regulated by Forkhead box transcription factor class O (FoxO), an ortholog of worm longevity gene daf-16. However, direct demonstration of FoxO involvement was hardly feasible because of the extremely low level of SMP30 expression in HepG2, probably reflecting lack of cofactor(s) for FoxO regulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金